Trial Profile
A double blind placebo controlled study on the effect of cerivastatin on the process of atherosclerosis in non-insulin dependent diabetes mellitus (type 2)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Nov 2022
Price :
$35
*
At a glance
- Drugs Cerivastatin (Primary)
- Indications Atherosclerosis; Diabetes mellitus; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms CERDIA
- 05 Feb 2007 New trial record.